Enterprises have spent the last decade doing a weird dance with documents: scanning them, storing them, indexing them, and then—at the most important moment—asking an employee to manually copy/paste the bits that actually matter. That’s not because businesses enjoy human-powered data entry (although some procurement departments appear to collect PDFs the way dragons collect gold).…
Scaling Intelligent Automation Without Breaking Live Workflows: Elastic Architecture, Governance, and Agentic AI Done Right
Somewhere in every enterprise, an automation engineer is staring at a dashboard that looks calm—too calm—while the business is one unexpected demand spike away from discovering that its “scaled” automation is really just a large collection of fragile scripts wearing a trench coat. That tension—between ambition and operational reality—sits at the heart of a recent…
From the Endpoint to the Prompt: Cloudflare One’s Unified Data Security Vision (and Why It Matters Now)
Enterprise security has always had a flair for reinvention. We rename the perimeter every few years, move the “center” of the network to wherever the most expensive incidents happen, and then we buy tools to match the new diagram. In 2026, the diagram has a new box labeled “AI prompts”—and it’s connected to everything. Cloudflare…
Gemini Live Agent Challenge: Google Cloud’s $80K Push for Real‑Time Multimodal AI (and What Devs Should Actually Build)
Google Cloud has a message for developers on March 7, 2026: stop typing, start talking, and ideally let your app “see” what you mean while you’re at it. In a new post on the Google Cloud Blog, Dilasha Panigrahi (Product Marketing Manager) announced the Gemini Live Agent Challenge, a Devpost-hosted hackathon aimed squarely at building…
OPENFOAM HPC Enterprise Solutions by Yobitel: What’s Actually “Enterprise” About Running OpenFOAM on AWS?
OPENFOAM in the cloud is one of those ideas that sounds trivial until you actually try to do it at scale. “Just spin up an instance and run the solver,” someone says — usually the same person who hasn’t yet discovered the joy of debugging MPI ranks at 2 a.m. while a deadline and a…
Unlocking Document Understanding with Mistral Document AI in Microsoft Foundry: What’s Actually New, Why It Matters, and How to Put It to Work
Enterprises have a long-running tradition of treating documents like a necessary evil: contracts that must be read, invoices that must be typed, forms that must be checked, and PDFs that must be… politely ignored until quarter end. If your organization has ever tried to “digitize” a business process and found that the biggest bottleneck is…
Countries Moving to Ban Social Media for Children: Australia’s Under‑16 Crackdown Spurs Europe and Southeast Asia
On March 6, 2026, TechCrunch consumer reporter Aisha Malik published a tidy list of governments “moving to ban social media for children.” It’s the kind of roundup that starts as a public-policy story and quickly mutates into a product requirements document for every platform on Earth: age verification, parental consent flows, enforcement dashboards, appeals processes,…
Before You Migrate: Five Surprising Ingress-NGINX Behaviors You Need to Know (and How Not to Break Prod in March 2026)
Kubernetes migrations have a special talent: they always seem to happen on the same week someone scheduled a “quick” upgrade, a holiday, or both. And if your clusters still rely on the community-maintained Ingress-NGINX controller, the calendar is no longer your friend: Kubernetes has announced that Ingress-NGINX will be retired in March 2026, and the…
Google Workspace CLI: The Command Line Is Back, and This Time It’s Bringing AI Agents to Gmail, Docs, and Sheets
Somewhere, a veteran sysadmin just felt a strange tingling sensation: the command line is cool again. On March 6, 2026, VentureBeat’s Carl Franzen reported on a new Google Workspace CLI that pulls Gmail, Google Drive, Calendar, Docs, Sheets, Chat, Admin, and “every Workspace API” into a single terminal-first interface designed for both humans and AI…
Converge Bio’s $25M Series A Is a Vote for “GenAI Labs” in Drug Discovery (and a Warning About Hallucinating Molecules)
On January 13, 2026, TechCrunch reported that Converge Bio, an AI drug-discovery startup with operations spanning Boston and Tel Aviv, raised $25 million in a Series A round. The round was led by Bessemer Venture Partners, with participation from TLV Partners, Saras Capital, and Vintage Investment Partners, plus backing from unnamed executives affiliated with Meta,…